Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity comparison of Marvel human insulin formulations versus Humulin in diabetes
2008-006763-36Phase 3Completed
- Sponsor
- Marvel Life Sciences
- Start
- Mar 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of human insulin in diabetes mellitus type 1 (T1D) and type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Marvel Life Sciences. Primary endpoint: Incidence of newly developed antibodies against insulin. Started Mar 2009; status: completed.
02
Drugs
human insulin
03
Conditions
diabetes mellitus type 1 (T1D)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2008-006763-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-006763-36.